Researcher
Debby Thomas
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Drug discovery and development, Pharmaceutics
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Jun 2017 → 30 Sep 2022 - Gynaecological Oncology (Division)
Member
From1 Mar 2014 → 31 May 2017 - Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Mar 2010 → 28 Feb 2014
Projects
1 - 2 of 2
- Symmetric antibodies for symmetric epitopes: development and validation of the Symbody platform.From1 Oct 2021 → TodayFunding: IOF - technology validation in lab
- Deciphering Tau structure and oligomerization propensities: Towards innovative therapeutics, prognostics and diagnosticsFrom1 Jan 2021 → 31 Dec 2023Funding: IOF - technology validation in lab
Publications
21 - 30 of 49
- Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model(2021)
Authors: Erwin Dreesen, Debby Thomas
Pages: 1587 - 1587 - Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations(2021)
Authors: Nathalie Van den Berghe, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Paul Declerck, Debby Thomas
Pages: 988 - 993 - Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission(2021)
Authors: Erwin Dreesen, Debby Thomas
Pages: 111 - + - Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients(2020)
Authors: Debby Thomas, Kristel Van Steen, Marc Hoylaerts, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 819 - 825 - Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations(2020)
Authors: Nathalie Van den Berghe, Séverine Vermeire, Marc Ferrante, Debby Thomas
- PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)(2020)
Authors: Claire Liefferinckx, Peter Bossuyt, Debby Thomas, Jean-Francois Rahier, Edouard Louis, Filip J Baert, Pieter Dewint, Lieven Pouillon, Guy Lambrecht, Séverine Vermeire, et al.
Pages: S456 - S456 - A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms(2020)
Authors: Joke Verelst, Nick Geukens, Vanessa Franssens, Joris Winderickx, Debby Thomas
- Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?(2019)
Authors: Debby Thomas
Pages: 945 - 954 - Dabrafenib plus trametinib in BRAF K601E-mutant melanoma(2019)
Authors: Aljosja Rogiers, Debby Thomas, Sara Vander Borght, Joost van den Oord, Oliver Bechter, Michael Dewaele, Chris Marine
Pages: 421 - 422 - Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models(2017)
Authors: Tine Cuppens, Jeroen Depreeuw, Daniela Annibali, Debby Thomas, David Debruyne, Philippe Moerman, Diether Lambrechts, Frédéric Amant
Pages: 538 - 545